Tag: RET-positive cancer drugs

Home / RET-positive cancer drugs

Categories

Selpercatinib is approved by FDA for RET fusion-positive thyroid cancer

  May 2024: The Food and Drug Administration has officially approved selpercatinib (Retevmo, Eli Lilly and Company) for the treatment of advanced or metastatic RET fusion-positive thyroid canc...
ret-positive-cancer-drugs

Scan the code